Mkrtichyan, MikayelChong, NamjuAbu Eid, RashaWallecha, AnuSingh, ReshmaRothman, JohnKhleif, Samir N.2018-04-092018-04-092013-08-29Mkrtichyan, M, Chong, N, Abu Eid, R, Wallecha, A, Singh, R, Rothman, J & Khleif, S N 2013, 'Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapy', Journal for immunotherapy of cancer, vol. 1, 15, pp. 1-9. https://doi.org/10.1186/2051-1426-1-152051-1426PubMedCentral: PMC4019896http://hdl.handle.net/2164/10308This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, NIH, Georgia Regents University Cancer Center (GRUCC) and Advaxis Inc. RAE is supported by a Fellowship Grant from King Hussein Institute for Biotechnology and Cancer (KHIBC, Jordan).9933938engSDG 3 - Good Health and Well-beingPD-1ImmunotherapyListeria-based vaccineCombinational immunotherapyQR180 ImmunologyRC0254 Neoplasms. Tumors. Oncology (including Cancer)QR180RC0254Journal article10.1186/2051-1426-1-15http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4019896&tool=pmcentrez&rendertype=abstracthttp://www.mendeley.com/research/antipd1-antibody-significantly-increases-therapeutic-efficacy-listeria-monocytogenes-lmllo-immunothe1